Kawasaki H - Search Results

1

Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1.

Murawaki Y, Ikuta Y, Kawasaki H. Murawaki Y, et al. Among authors: kawasaki h. Clin Chim Acta. 1999 Mar;281(1-2):109-20. doi: 10.1016/s0009-8981(98)00215-0. Clin Chim Acta. 1999. PMID: 10217632

2

Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis.

Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Murawaki Y, et al. Among authors: kawasaki h. J Hepatol. 1995 Aug;23(2):145-52. doi: 10.1016/0168-8278(95)80328-9. J Hepatol. 1995. PMID: 7499785

3

Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.

Fujii T, Horie Y, Ikuta Y, Nishimuki E, Murawaki Y, Suou T, Kawasaki H. Fujii T, et al. Among authors: kawasaki h. Clin Chim Acta. 1995 Apr 30;236(1):71-9. doi: 10.1016/0009-8981(95)06042-6. Clin Chim Acta. 1995. PMID: 7545092

4

Serum collagenase activity in chronic liver diseases.

Murawaki Y, Kawasaki H, Burkhardt H. Murawaki Y, et al. Among authors: kawasaki h. Pathol Res Pract. 1994 Oct;190(9-10):929-33. doi: 10.1016/S0344-0338(11)80998-2. Pathol Res Pract. 1994. PMID: 7899142

5

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.

Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Murawaki Y, et al. Among authors: kawasaki h. Hepatology. 1994 Oct;20(4 Pt 1):780-7. doi: 10.1002/hep.1840200403. Hepatology. 1994. PMID: 7927217

6

Serum collagenase activity in patients with chronic liver disease.

Murawaki Y, Koda M, Yamada S, Kawasaki H, Shima H, Burkhardt H. Murawaki Y, et al. Among authors: kawasaki h. J Hepatol. 1993 Jul;18(3):328-34. doi: 10.1016/s0168-8278(05)80277-6. J Hepatol. 1993. PMID: 8228126

7

Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.

Murawaki Y, Yamamoto H, Kawasaki H, Shima H. Murawaki Y, et al. Among authors: kawasaki h. Clin Chim Acta. 1993 Sep 17;218(1):47-58. doi: 10.1016/0009-8981(93)90221-o. Clin Chim Acta. 1993. PMID: 8299219

8

Portal blood velocity and portal blood flow in patients with chronic viral hepatitis: relation to histological liver fibrosis.

Koda M, Murawaki Y, Kawasaki H, Ikawa S. Koda M, et al. Among authors: kawasaki h. Hepatogastroenterology. 1996 Jan-Feb;43(7):199-202. Hepatogastroenterology. 1996. PMID: 8682462

9

Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.

Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Murawaki Y, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 1996 May;11(5):443-50. doi: 10.1111/j.1440-1746.1996.tb00289.x. J Gastroenterol Hepatol. 1996. PMID: 8743916

10

Clinical significance of serum hyaluronan in patients with chronic viral liver disease.

Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. Murawaki Y, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 1996 May;11(5):459-65. doi: 10.1111/j.1440-1746.1996.tb00291.x. J Gastroenterol Hepatol. 1996. PMID: 8743918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,364 results

Search Page

Filters